Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins attenuate sepsis.

Austin L Spitzer1, Hobart W Harris

  • 1Department of Surgery, University of California, San Francisco-East Bay, 1411 E. 31st Street, Oakland, CA 94602, USA. spitzera@surgery.ucsf.edu

Surgery
|March 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Bile Duct Transection Injury in an Integrated System.

The Permanente journal·2026
Same author

Ventral hernia repair with T-line hernia mesh: A multi-institutional experience.

Surgery in practice and science·2025
Same author

The Inflammatory Landscape of a Whole-Tissue Explant Model of Hidradenitis Suppurativa.

Experimental dermatology·2025
Same author

Innovations for Incisional Hernia Prevention.

Journal of abdominal wall surgery : JAWS·2024
Same author

Quality of life measures and cost analysis of biologic versus synthetic mesh for ventral hernia repair: The Preventing Recurrence in Clean and Contaminated Hernias randomized clinical trial.

Surgery·2023
Same author

Biologic Versus Synthetic Mesh in Ventral Hernia Repair: Participant-Level Analysis of Two Randomized Controlled Trials at Twenty-Four to Thirty-Six Months.

Surgical infections·2023

Statins may reduce the severity of sepsis by helping the body clear endotoxins. This cholesterol-lowering drug class also appears to decrease inflammation associated with Gram-negative sepsis.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • 3-hydroxy-3-methylglutaryl-coenzyme reductase inhibitors (statins) are key regulators of cholesterol synthesis.
  • Gram-negative sepsis involves a systemic response to bacterial lipopolysaccharide (endotoxin).
  • Low-density lipoprotein receptors play a role in clearing lipoproteins and endotoxins.

Purpose of the Study:

  • To investigate the potential of statins to enhance endotoxin clearance and attenuate the septic response.
  • To explore the role of low-density lipoprotein receptors in mediating statin effects during sepsis.

Main Methods:

  • The study outlines a hypothetical mechanism based on existing knowledge of cholesterol metabolism, sepsis pathophysiology, and receptor-mediated endocytosis.
  • It posits that statins' effects on cholesterol synthesis and low-density lipoprotein receptor expression are central to their proposed action in sepsis.

Related Experiment Videos

Main Results:

  • Statins may enhance the clearance of endotoxin from the circulation.
  • The mechanism involves the upregulation of low-density lipoprotein receptors, which bind and internalize endotoxin-bound lipoproteins.
  • This process may co-opt the NF-kappaB pathway, reducing cellular inflammatory responses.

Conclusions:

  • Statins possess a potential dual action: lipid reduction and augmentation of endotoxin clearance.
  • These effects suggest statins could be a therapeutic strategy to mitigate the severity of Gram-negative sepsis.
  • Further research is warranted to validate these proposed mechanisms and clinical implications.